Westside Investment Management, Inc. - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 25 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q3 2023$2
-33.3%
40.0%0.00%
Q2 2023$30.0%40.0%0.00%
Q1 2023$340.0%0.00%
Q4 2022$040.0%0.00%
Q3 2022$040.0%0.00%
Q2 2022$040.0%0.00%
Q1 2022$040.0%0.00%
Q4 2021$040.0%0.00%
Q3 2021$040.0%0.00%
Q2 2021$04
-50.0%
0.00%
Q1 2021$080.0%0.00%
Q4 2020$080.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 33,309$87,0000.01%
Advisory Services Network, LLC 9,000$23,0000.00%
Westside Investment Management, Inc. 4$00.00%
American Portfolios Advisors 23$600.00%
JPMORGAN CHASE & CO 19$00.00%
VANGUARD GROUP INC 204,324$531,0000.00%
UBS Group AG 8,272$22,0000.00%
Sargent Bickham Lagudis LLC 2$00.00%
OSAIC HOLDINGS, INC. 15$00.00%
FMR LLC 1$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders